FDA clears eScreen's drugs-of-abuse test:
This article was originally published in Clinica
Executive Summary
eScreen has received US FDA 510(k) clearance to market its automated, in-vitro drugs-of-abuse screening system, which the company claims is the first device for use in prescription workplace drug testing. The device provides a negative result within minutes, says the Overland Park, Kansas firm.